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http://dxFrailty is a common occurrence in elderly persons and is present in approximately half of the patients being
screened for transcatheter aortic valve replacement (TAVR) therapy. Accurate assessment of the likelihood of
benefit from intervention in the older patient with aortic stenosis is critical with both surgical aortic valve re-
placement and TAVR now available. Whereas risk algorithms are available that are helpful in predicting out-
comes in patients undergoing surgical procedures, measures of frailty are not included in the algorithms.
When considering intervention in the elderly patient, the addition of frailty assessment to determine the true
risk in this population is essential to determine potential benefit. Gait speed as determined by the 5-m walk
test is the most commonly used single test objective measurement of frailty in patients undergoing cardiac
surgery and is an independent predictor of mortality and major morbidity. Wider application of this and other
objective measures of frailty in the population undergoing TAVR is necessary to determine whether it is predic-
tive in this population also. (J Thorac Cardiovasc Surg 2013;145:S7-10)Frailty is a commonly encountered condition in elderly pa-
tients that needs to be considered when weighing treatment
options. Although frailty is a relatively easy concept to
describe, it is much more difficult to define and measure
clinically. Akin to Supreme Court Justice Potter Stewart’s
oft-quoted pronouncement on pornography, ‘‘I can’t define
it, but I know it when I see it,’’ most physicians face the
same conundrum when assessing frailty.1 Clinicians often
euphemistically refer to the ‘‘eyeball test’’ or ‘‘end of the
bed-o-gram’’ when assessing the likelihood that a patient
will survive and receive benefit from a contemplated
procedure.
The ability to understand procedural risks in the frail el-
derly patient is necessary to guide decision making. Many
risk algorithms have been developed that take into account
age and comorbid medical conditions, and models based on
these have been constructed that are predictive of outcomes
after surgical procedures. However, defining frailty, mea-
suring the role it plays in outcomes, and incorporating
frailty parameters into risk algorithms have proved elusive.2
Although risk increases with chronologic age and comor-
bidity, these factors alone are insufficient to predict out-
comes and benefit. More discriminatory assessments are
needed to understand why, despite equal measured risk,
some individuals do well whereas others do not.
DEFINING FRAILTY IN ELDERLY PATIENTS
The elderly population is growing and living longer. In the
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The Journal of Thoracic and Caalmost 9 years of life expectancy, so that treatments that
can optimize the quality of remaining years of life are of
great potential value.3 However, with age comes a loss in
complex adaptations across organ systems, yet substantial
heterogeneity in biological aging is known.4 Those who
are least adaptive to the process of aging, we define as frail.
Frailty is formally defined as a clinical syndrome of mul-
tisystem impairment that results in a decreased physiologic
reserve and an increased vulnerability to stressors.5 The bi-
ology of frailty has been associated with shortened telo-
meres, cell senescence, a generalized catabolic state, and
alterations in brain neurotransmitters, inflammatory, and
coagulation pathways.6 The phenotype of frailty can be
described as decreased physical function associated with
sarcopenia, osteopenia, and cognitive impairments.7 Fur-
thermore, frailty, or declines in organ and physiologic
reserves, may be ‘‘subclinical’’ and apparent only in
hindsight.
The prevalence of frailty in community-dwelling elders
is about 15% at age 70 years and increases to 40% past
age 85 years, whereupon there is no further increase.8 Al-
though it is rare to find frail individuals under age 70 years,
prevalence never exceeds 50% even past age 90 years, be-
cause frail individuals do not survive to the oldest ages.9
Frailty is dynamic to some degree, with frailty criteria dis-
appearing over time in up to 20% of frail individuals, as
well as developing over time in others.8 Frailty, easy to de-
scribe as a concept, is more complicated to capture and de-
fine for several reasons. First, frailty is distinct from
comorbidity and disability, both of which are commonly
collected conditions. In fact, in the Cardiovascular Health
Study, 27% of people with frailty had no comorbidity or
disability.5 Comorbidity and disability overlap with frailty,
but disability is considered an outcome asmuch as a descrip-
tor. Comorbidity—specifically the sum of noncardiac co-
morbidities—is a marker of advanced risk, but itself is not
frailty. This suggests that aspects of frailty may be amenable
to intervention. In the most frail of patients, the degree ofrdiovascular Surgery c Volume 145, Number 3S S7
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replacementThe Journdebilitation can be such that the likelihood of meaningful
functional recovery after a successful procedure is small.
This leads to the clinical quandary of ‘‘utility versus futil-
ity.’’ The question is: can we define the degree of the vulner-
ability to stressors that is so great that despite a successful
intervention to cure or alleviate a particular condition,
long-term survival, meaningful recovery, and improved
quality of life and functional outcomes are unlikely to
occur?
MEASURING FRAILTY
There is no gold standard for defining frailty, and the
range of available measures raises issues as to how to collect
this consistently. Although the eyeball test is appealing,
there is too much variability from patient to patient and
from physician to physician because of lack of objectivity
and varying experience. The available frailty scores are ob-
jective but are limited by lack of prospectively available
data values, especially in patients undergoing surgical or in-
terventional procedures, and capture only some aspects of
frailty in selected organ systems. Moreover, it is relatively
cumbersome and time-consuming in a busy clinical practice
to gather sufficient information to truly capture frailty.
There are more than 20 multidimensional frailty scales in
the published literature that capture aspects of slowness,
weakness, low activity, exhaustion, cognitive impairment,
and nutrition, among others7,9,10 (Table 1). Geriatric impair-
ments (falls, incontinence) have also been included in these
composite scores. Physical performance assessments such
as gait speed and grip strength offer advantages in that
they are objective, statistically robust, and capture the inte-
grated function of the individual. These continuous mea-
sures can be analyzed at various cut points and require no
language translation, in contrast to the subjective activity
questionnaires. In a pooled analysis of individual data
from 9 selected cohorts studying survival in elderly persons,
gait speed was associated with survival in older adults.10
FRAILTY IN PATIENTS WITH CARDIAC DISEASE
As one would expect, the prevalence of frailty in the
elderly population with cardiac disease is great andal of Thoracic and Cardiovascular Surgecarries prognostic significance. In a review of 9 studies en-
compassing 54,250 elderly patients with a mean weighted
follow-up of 6.2 years, cardiovascular disease was associ-
ated with an odds ratio (OR) of 2.7 to 4.1 for prevalent
frailty and an OR of 1.5 for incident frailty in those who
were not frail at baseline. Gait velocity as a measure of
frailty was associated with an OR of 1.6 for incident cardio-
vascular disease. In elderly patients with documented se-
vere coronary artery disease or heart failure, the
prevalence of frailty was 50% to 54%, and this was associ-
ated with an OR of 1.6 to 4.0 for all-cause mortality after
adjusting for potential confounders.11 The prevalence of
frailty was also defined in a recent study of hospitalized
older adults with severe coronary artery disease.12 With
the use of gait speed, grip strength, and chair stands, 2
frailty phenotypes (composite A and composite B) were de-
fined in 309 consecutive inpatients aged 70 years and older
with a minimum of 2-vessel coronary artery disease. This
was then correlated with 6-month mortality. The prevalence
of frailty was 27% for composite A versus 63% for com-
posite B. The utility of single-item measures for identifying
frailty was greatest for gait speed, followed by chair stands
and grip strength. Slow gait speed (0.65 m/s) and poor
grip strength (25 kg) were the strongest predictors of
6-month mortality.
FRAILTY IN PATIENTS WITH AORTIC STENOSIS
In the evaluation of frailty in patients with aortic stenosis,
an additional question, is howmuch of a role does the aortic
stenosis play in frailty? The implications are 2-fold. First,
the patient may be too frail to survive a procedure to relieve
the aortic stenosis. Second, even if the patient survives the
procedure, what is the likelihood that the frailty will im-
prove and that there will be an improved quality of life
and functional outcome?
The prevalence of frailty in aortic stenosis was recently
defined in a series of 102 older adults being screened for
transcatheter aortic valve replacement (TAVR).13 Sixty-
three percent of patients had a slow gait speed (<0.5 m/s).
There was a strong association between slow gait speed
and dependent functional status, with the authors conclud-
ing that assessment of gait speed is a useful, objectively
measurable risk stratification tool in this population.
In our own center, we have tested gait speed in 200 con-
secutive patients with aortic stenosis being screened for
TAVR; 53.5% of patients, mean age 80.5  8.8 years,
met the criteria for frailty, with a gait speed of less than 6
seconds for the 5-m walk test. Clinicians were blinded as
to the results of gait speed when evaluating these patients.
Patients with normal gait speed were more often selected
for surgical aortic valve replacement than those with
a slower gait speed, whowere more often treated with either
TAVR or medical therapy. This suggests to us that gait
speed may be an objective surrogate for the eyeball test.ry c March 2013
TABLE 1. Tests for measurement of frailty in different domains
 Slowness:
 Gait speed (walk time)
 Get up and go
 Chair stands
 Balance
 SPPB
Weakness:
 Grip strength
 Calf circumference
 Low activity:
 Physical function (SF-36 PF, DASI)
 Inactivity
 Minnesota Leisure Time Scale
 Exhaustion:
 Fatigue scales (CES-D)
 Cognitive impairment:
 MMSE
 TICS-M
 Dementia
 Trails Test
Word Recall
 Clock Drawing
 Nutrition:
 Body mass index
Weight loss
 Other:
 Activities of daily living
 Falls
 Hearing or vision impairment
 Polypharmacy
 Incontinence
 Comorbidity count
 Depression (GDS)
 Mood disturbance
SPPB, Short Physical Performance Battery; SF-36 PF, Short Form–36, physical func-
tioning;DASI,Duke Activity Status Index; CES-D, Center for Epidemiological Stud-
ies Depression Scale; MMSE, mini–mental state examination; TICS-M, Modified
Telephone Interview for Cognitive Status; GDS, Geriatric Depression Scale.
Mack Panel 1Whether frailty as defined by gait speed is a determinant of
outcomes after TAVR, however, remains to be determined.
FRAILTY IN PATIENTS UNDERGOING CARDIAC
SURGERY
The use of tools for the assessment of frailty in patients
undergoing cardiac surgery is increasing. In a multicenter
prospective cohort of 131 elderly patients undergoing car-
diac surgery at 4 tertiary care hospitals, the value of gait
speed—a clinical marker for frailty—was used to improve
the prediction of mortality and major morbidity.14 Patients
were eligible for the study if they were 70 years of age or
older and were scheduled for coronary artery bypass and/
or valve replacement or repair. Sixty (46%) patients were
classified as slow walkers before cardiac surgery: they
were more likely to be female (43% vs 25%; P ¼ .03)
and diabetic (50% vs 28%; P¼ .01). Thirty (23%) patientsThe Journal of Thoracic and Cahad the primary composite end point of mortality or major
morbidity after cardiac surgery. Slow gait speed was an in-
dependent predictor of this composite end point after ad-
justing for The Society of Thoracic Surgeons (STS) risk
score (OR, 3.05; 95% confidence interval [CI], 1.23-7.54).
These findings were subsequently amplified by another
study by the same authors.15 The study hypothesis was
that cardiac surgery risk scores perform poorly in elderly
patients, in part because they do not take into account frailty
and disability, which are critical determinants of health sta-
tus with advanced age. Combining established cardiac sur-
gery risk scores with measures of frailty and disability could
provide a more complete model for risk prediction in
elderly patients undergoing cardiac surgery.
Four different frailty scales, 3 disability scales, and 5 car-
diac surgery risk scores were measured in all patients. The
primary outcome was the STS composite end point of in-
hospital postoperative mortality or major morbidity. A total
of 152 patients were enrolled, with a mean age of 75.9 4.4
years; 34% were women. Depending on the scale used,
20% to 46% of patients were found to be frail, and 5%
to 76% were found to have at least 1 disability. The most
predictive scales in each domain were as follows: 5-m
gait speed greater than 6 seconds as a measure of frailty
(OR, 2.63; 95% CI, 1.17-5.90); more than 3 impairments
in the Nagi scale as a measure of disability (OR, 2.98;
95% CI, 1.35-6.56), and either the Parsonnet score (OR,
1.08; 95%CI, 1.04-1.13) or the STS Predicted Risk of Mor-
tality or Major Morbidity (STS-PROMM) (OR, 1.05; 95%
CI, 1.01-1.09) as a cardiac surgery risk score.16 The authors
concluded that clinicians should use an integrative approach
combining frailty, disability, and risk scores to better char-
acterize elderly patients referred for cardiac surgery to iden-
tify those that are at increased risk.
Another recent additional ‘‘comprehensive assessment of
frailty’’ was performed in 400 patients undergoing cardiac
surgery, mean age 74 years.17 The frailty score combined
characteristics of the Fried criteria, patient phenotype,
physical performance, and laboratory results. Patients un-
derwent isolated coronary artery bypass grafting (n ¼ 90),
isolated valve surgery (n ¼ 128), transcatheter valve im-
plantation (n ¼ 59), or combined procedures (n ¼ 123).
The primary end point was the correlation of a frailty score
to 30-day mortality. There were low-to-moderate albeit sig-
nificant correlations of the frailty score with the STS score
and EuroSCORE (P< .05). There was also a significant
correlation between the frailty score and observed 30-day
mortality (P<.05). The authors concluded that a compre-
hensive assessment of frailty is an additional tool to evalu-
ate elderly patients adequately before cardiac surgical
interventions and that a combination of the new frailty score
and the traditional scoring systems may facilitate more ac-
curate risk scoring in elderly high-risk patients scheduled
for conventional cardiac surgery or TAVR.rdiovascular Surgery c Volume 145, Number 3S S9
TABLE 2. Tests for assessment of frailty in the PARTNER Trial
1. Grip strength (<18 kg)
2. 5-m walk (>6 s)
3. Serum albumin (<3.5 mg/dL)
4. Katz ADLs (4/6 or less)
PARTNER Trial, Placement of AoRTic TraNscathetER Valve Trial; ADLs, activities
of daily living.
Panel 1 MackBecause of the shortcomings of the current risk predic-
tion models in elderly patients undergoing cardiac surgery,
and based on some of the aforementioned studies, frailty as
determined by gait speed has recently been added to the
STS Database (version 2.73) starting July 2011.
In the PARTNER Trial of TAVR, frailty parameters are
being prospectively collected as a routine part of evaluation
for entry into the trial. A frailty index is being used to clas-
sify patients as frail. For frailty to be the sole or primary rea-
son for inoperability, 3 of 4 criteria listed in Table 2 must be
fulfilled.
CONCLUSIONS
As the population ages, accurate assessment of the likeli-
hood of benefit from intervention in the elderly is critical.
This is especially true in the older patient with aortic steno-
sis, in whom less invasive therapeutic options have become
available. The ability to distinguish those patients who are
dying of aortic stenosis from thosewho are dyingwith aortic
stenosis can be a perplexing clinical conundrum. The deter-
mination of ‘‘utility versus futility,’’ wherein there is the
possibility of no improvement in quality of life even if the
patient undergoes a successful procedure, is gaining in-
creasing importance. Many risk algorithms are available
that accurately predict outcomes after cardiac surgery.
They all lose accuracy, however, when applied to the
elderly population in whom other factors that are not ac-
counted for in the various predictive models—such as
frailty—predominate.
Frailty is a common occurrence in elderly persons, char-
acterizing between 40% and 70% of the population stud-
ied. It occurs in approximately half the candidates being
screened for transcatheter aortic valve therapy. Gait speed
as determined by the 5-m walk test is the most commonlyS10 The Journal of Thoracic and Cardiovascular Surgused single test objective measurement of frailty in patients
undergoing cardiac surgery and is an independent predictor
of mortality and major morbidity. Wider application of this
and other measures of frailty in the population undergoing
TAVR will be necessary to determine whether it is also pre-
dictive in this population undergoing this interventional
procedure.
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